S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma.
| Image |  |
|---|---|
| Description | scientific article published on 28 May 2013 |
| Author/s |
author: Pascal Hammel Thierry André Alain Sauvanet Jean-Baptiste Bachet Jérôme Cros |
| Publication date | May 28, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |